TIXiMED Chief Scientific Officer Presents at 2023 Immunology of Diabetes Society Congress tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
ImmPrev Bio, Inc Receives Exclusive License to Commercialize a Diagnostic Tool and Early-Stage Treatment for Crohn s Disease tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Dr. Anath Shalev, renowned diabetes researcher and Chief Scientific Officer of TIXiMED, Inc., a company dedicated to the development and commercialization of TXNIP inhibiting medications, presented her work on verapamil and TXNIP inhibition at the 2023 Immunology of Diabetes Society Congress in Paris.BIRMINGHAM, Ala.
/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic-derived therapies for use in the treatment of.